Ranbaxy Laboratories
Latest Ranbaxy Laboratories News
-
Generic Lipitor Production Halted to Clear Glass From CapsulesRanbaxy Pharmaceuticals Inc ., the company that makes a generic medicine in the country. India-based Ranbaxy produces one of every three of the generic Federal Drug Administration overnight said Ranbaxy has agreed to stop manufacturing Atorvastatin
-
Senators Pan Pfizer’s Plan to Block Generic Lipitor
Wednesday, the U.S. Food and Drug Administration approved the first generic version of Lipitor, made by Ranbaxy Laboratories Ltd . Ranbaxy has exclusive rights to sell the generic for 180 days, during which time it will be Lipitor’s sole competitor
-
Consumers Will Pay Half as Much for Generic Version of Lipitor
consumers who want to switch to the generic right away. Ranbaxy Laboratories , the manufacturer with exclusive rights to sell atorvastatin total of nearly $1 billion. After the next 180 days, Ranbaxy 's exclusive rights to sell the generic drug will
-
Lipitor Among Top Drugs Coming Off Patentmanaged to hold off competition until later this year. Ranbaxy , an India-based pharmaceutical company, agreed to delay of Lipitor until Nov. 30. According to its website, Ranbaxy will have the exclusive right to sell its drug in the U
-
Health Highlights: May 5, 2009
release, UPI reported. ----- Ranbaxy Announces U.S. Recall of Antibiotic announced by India-based drug maker Ranbaxy . The recall of 100-milligram capsules said a statement released by Ranbaxy , which gave no details about the
-
Health Highlights: May 4, 2009
compiled by editors of HealthDay: Ranbaxy Announces U.S. Recall of Antibiotic announced by India-based drug maker Ranbaxy . The recall of 100-milligram capsules said a statement released by Ranbaxy , which gave no details about the
News
-
FDA Halts New Applications From Indian Drug Maker's Plant
any new drug applications from a Ranbaxy Laboratories plant in India after determining was falsifying scientific data. Ranbaxy , based in India, is one of the less than six months. "No other Ranbaxy facilities are directly affected
-
Health Highlights: Oct. 22, 2008
continues its investigation of the agency's handling of problems at two Indian plants run by generic drug maker Ranbaxy Laboratories . In September, the FDA banned import of 30 generic drugs produced at the two plants. The action came several
-
FDA Bars Generic Drugs From Indian Company
drugs made by Indian drug maker Ranbaxy Laboratories Ltd . are being denied entry into the Administration announced Tuesday. Ranbaxy is one of the world's largest meet consumer demand. However, Ranbaxy is the sole U.S. supplier of
-
As Seen On TV: FDA Generic Drug Import Ban
widely used generic drugs made by Ranbaxy Laboratories Ltd ., a major manufacturer in India generic drugs produced at two of Ranbaxy 's plants. People taking any of amounts, produced at two of Ranbaxy 's facilities. Click here to
-
FDA Bans Import of Meds From Major Drug MakerAlavert and Claritin, all made at two Ranbaxy plants in India, could be affected Evaluation and Research. Based in India, Ranbaxy has already been under investigation offices in New Jersey. Last year, Ranbaxy recalled 73 million doses of a generic
-
Feds Allege Ranbaxy Lied About Quality of Drugs
that Indian generic drugmaker Ranbaxy Laboratories deliberately misled the U.S Justice Department is demanding Ranbaxy turn over documents which it hopes filing asks the court to order Ranbaxy to turn over the documents. Ranbaxy
-
Health Highlights: June 18, 2008
reached between Pfizer Inc. and Ranbaxy Laboratories Ltd . of India. "The agreement provides generic product much earlier than if Ranbaxy were unsuccessful in obtaining market. The deal also permits Ranbaxy to sell generic versions of Lipitor
Videos
-
FDA Bans Generic Indian DrugsImports of more than 30 drugs made by Ranbaxy Laboratories are being blocked.
-
Ranbaxy : Generic Lipitor Producer's Plant Shuts Downthree of the generic lipitor pills, ranbaxy , has agreed to stop producing it glass. Overnight, the fda said ranbaxy , the company responsible for making doesn't expect an immediate shortage. Ranbaxy first issued recalls on november
company that produces one of every three of the generic lipitor pills, ranbaxy , has agreed to stop producing it, because some of the bottles are laced with glass. Overnight, the fda said ranbaxy , the company responsible for making all of those allegedly glass-covered pills. The company has real difficult with quality control. Reporter: The fdadrug, there are other manufacturers and it doesn't expect an immediate shortage. Ranbaxy first issued recalls on november 9th because of glass contamination. According to the government and doctors actually sounds worse than it isfrom users. The concerns are about quality control. We reached out to ranbaxy but did not get a response. -
Generic Lipitor Warning: Manufacturer Halts Production of Drugdown all production. The problem? Ranbaxy can't figure out how small glass lipitor costs $4.72 a pill. The ranbaxy pill, just $3.85. This is the because of bad record-keeping. Ranbaxy won't say where these pills are
pills taken in this country has shut down all production. The problem? Ranbaxy can't figure out how small glass particles have gotten into its generic pills. The contamination has not led to any patient problems. But consumers are being told to return their pills and get another brand. Generics are popular because of their price. Name brand lipitor costs $4.72 a pill. The ranbaxy pill, just $3.85. This is the latest manufacturing problem for r nba axy. Earlier this year, the u.S. Government forbid the company from importing 30 drugs from some of its facilities in india, because of bad record-keeping. Ranbaxy won't say where these pills are made. The fda says it can't comment whether ranbaxy violated the rules. The company has real difficulties with galty control, not just in one of a couple of its facilities, but
